Sea Mild Biotechnology Co., Ltd. (TPEX:7516)
Taiwan · Delayed Price · Currency is TWD 8.63
+0.27 (3.23%)
Oct 8, 2026, 1:54 PM CST
Sea Mild Biotechnology Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 167 | 195 | 237 | 220 | 73 | 154 | |
Market Cap Growth | -5.16% | -17.89% | 7.90% | 200.00% | -52.50% | -33.90% |
Enterprise Value | 209 | 220 | 242 | 215 | 64 | 144 |
Last Close Price | 8.63 | 10.10 | 12.30 | 11.40 | 3.80 | 8.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 25.31 | 22.07 | 7.43 | 35.58 | - | - |
PS Ratio | 0.45 | 0.57 | 0.75 | 0.86 | 0.36 | 0.94 |
PB Ratio | 1.47 | 1.76 | 2.32 | 3.13 | 1.14 | 1.80 |
P/TBV Ratio | 1.47 | 1.76 | 2.32 | 3.13 | 1.14 | 1.82 |
P/FCF Ratio | - | - | 10.34 | 29.00 | 6.27 | - |
P/OCF Ratio | 13.02 | 25.55 | 6.93 | 24.91 | 6.27 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.56 | 0.64 | 0.76 | 0.84 | 0.32 | 0.88 |
EV/EBITDA Ratio | 8.02 | 12.33 | 8.59 | 29.18 | - | - |
EV/EBIT Ratio | 60.21 | 30.51 | 10.84 | 44.56 | - | - |
EV/FCF Ratio | - | - | 10.52 | 28.37 | 5.46 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.94 | 0.99 | 0.56 | 0.63 | 0.39 | 0.29 |
Debt / EBITDA Ratio | 4.10 | 3.57 | 1.39 | 2.29 | 7.95 | - |
Debt / FCF Ratio | - | - | 2.50 | 5.83 | 2.17 | - |
Net Debt / Equity Ratio | 0.37 | 0.18 | -0.25 | -0.03 | -0.24 | -0.16 |
Net Debt / EBITDA Ratio | 3.49 | 1.13 | -0.91 | -0.32 | 1.97 | 0.63 |
Net Debt / FCF Ratio | -5.52 | -2.74 | -1.11 | -0.31 | -1.30 | 0.91 |
Asset Turnover | 1.19 | 1.18 | 1.43 | 1.48 | 1.24 | 0.79 |
Inventory Turnover | 3.74 | 4.01 | 5.24 | 8.81 | 8.79 | 5.82 |
Quick Ratio | 0.81 | 0.95 | 0.98 | 0.92 | 1.21 | 1.37 |
Current Ratio | 1.36 | 1.45 | 1.45 | 1.33 | 1.51 | 1.74 |
Return on Equity (ROE) | 5.95% | 8.30% | 37.02% | 9.17% | -28.45% | -46.54% |
Return on Assets (ROA) | 0.70% | 1.55% | 6.24% | 1.74% | -4.59% | -9.58% |
Return on Invested Capital (ROIC) | 2.22% | 6.95% | 29.86% | 8.24% | -19.76% | -33.35% |
Return on Capital Employed (ROCE) | 2.40% | 4.90% | 21.00% | 6.30% | -15.70% | -31.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.95% | 4.53% | 13.47% | 2.81% | -29.14% | -33.70% |
FCF Yield | -4.60% | -3.79% | 9.67% | 3.45% | 15.96% | -9.84% |